Psyence Biomedical (PBM) Short-term Investments (2023 - 2025)

Psyence Biomedical's Short-term Investments history runs 3 years deep, the most recent figure standing at $47191.0 for Q3 2025.

• In Q3 2025, Short-term Investments rose 59.37% year-over-year to $47191.0; the TTM figure through Sep 2025 stood at $47191.0 (up 59.37% YoY), while the FY2025 annual figure was $35964.0, up 21.45% from the prior year.
• Short-term Investments was $47191.0 for Q3 2025 at Psyence Biomedical, up from $35964.0 in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $47191.0 in Q3 2025 to a low of $29556.0 in Q1 2023.
• Historically, Short-term Investments has averaged $34386.6 across 3 years, with a median of $29611.0 in 2024.
• The sharpest annual moves came in 2024 and 2025: Short-term Investments grew 0.19% in 2024, then soared 59.37% in 2025.
• A 3-year view of Short-term Investments shows it stood at $29556.0 in 2023, then gained by 0.19% to $29611.0 in 2024, then surged by 59.37% to $47191.0 in 2025.
• The last three Short-term Investments figures came in at $47191.0 (Q3 2025), $35964.0 (Q1 2025), and $29611.0 (Q3 2024), per Business Quant data.